Latest Breaking News On - Alethia young cantor fitzgerald - Page 3 : comparemela.com
Regeneron Pharmaceuticals Inc (REGN) Q2 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
Sarepta Therapeutics (SRPT) Q2 2021 Earnings Call Transcript
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Alnylam Pharmaceuticals Q2 2021 Earnings Call. [Operator Instructions]
I would now like to turn the call over to your host, Christine Lindenboom. You may begin.
Christine Regan Lindenboom
Senior Vice President, Investor Relations and Corporate Communications
Good morning. I m Christine Lindenboom, Senior Vice President of Investor Relations and Corporate Communications at Alnylam. With me today on the phone are John Maraganore, Chief Executive Officer; Tolga Tanguler, Chief Commercial Officer; Akshay Vaishnaw, President of R&D Jeff Poulton, Chief Financial Officer; and Yvonne Greenstreet, President and Chief Operating Officer. For those of you participating via conference call, the accompanying slides can be accessed by going to the Events section of the Investors page of our website, investors.alnylam.com/events. During today s call, as outlined in Slide 2, John will provide some introductory remark
Operator
Greetings, and welcome to Global Blood Therapeutics conference call. [Operator instructions] As a reminder, this conference is being recorded. I would now like to turn the call over to Steven Immergut. Please go ahead, sir.
Steven Immergut
Investor Relations
Thank you, and welcome to GBT s conference call to discuss the company s financial results for the second-quarter 2021 and to provide a business update. I m Steven Immergut, head of communications and investor relations. Joining me on the call are Dr. Ted Love, our president and CEO, will provide an update on our progress in the second quarter; Jeff Farrow, our chief financial officer, will review our financial results; David Johnson, or DJ, our chief commercial officer, will give an update on the Oxbryta launch; Dr.
Greetings. Welcome to TG Therapeutics Second Quarter 2021 Earnings Call and Business Update. [Operator Instructions]
At this time, I will now turn the conference over to Jenna Bosco, Senior Vice President of Corporate Communications. Jenna, you may now begin.
Jenna Bosco
Senior Vice President, Corporate Communications
Thank you. Welcome everyone and thanks for joining us this morning. I m Jenna Bosco and with me today to discuss the second quarter 2021 financial results and provide a business update are Michael Weiss, our Chairman and Chief Executive Officer; Adam Waldman, our Chief Commercialization Officer; and Sean Power, our Chief Financial Officer. Following our Safe Harbor statement, Mike will provide an overview of our recent corporate developments as well as an update on our current pivotal programs and remaining key goals for 2021. Adam will then provide an update on our commercialization efforts and Sean will provide a brief overview of our financial results, before
vimarsana © 2020. All Rights Reserved.